Nuvalent, Inc.

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domai…

Biotechnology

US, Cambridge [HQ]

Competitors · Subsidiaries · Locations

Context Analysis

Competitors · Subsidiaries · Locations

The Contextualizer is eligible to "contextualize" the market relationships of Nuvalent, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices, fabrics and competitors around the globe.

Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.

U.S. · Business Intelligence

The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.

Worldwide · Business Intelligence

The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.

Worldwide · Competitors Table

Sourced from FMP or manual.

Competitor	Source	Accuracy	Country	City
DICE Therapeutics, Inc.	FMP	High	United States	South San Francisco
United Therapeutics Corporation	FMP	High	United States	Silver Spring
Cerevel Therapeutics Holdings, Inc.	FMP	High	United States	Cambridge
Vaxcyte, Inc.	FMP	High	United States	San Carlos

Worldwide · Subsidiaries Table

Sourced from the SEC, through government awards and manual entries.

Subsidiary	Private?	Country	City
-	-	-	-